Vyne Therapeutics Inc (VYNE)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
David T. Domzalski
Employees:
43
520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
800-775-7936

VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology

Data derived from most recent annual or quarterly report
Market Cap 60.784 Million Shares Outstanding51.512 Million Avg 30-day Volume 713.452 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 13.2 / 1.08 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million

Are you looking for this stock instead?

View SEC Filings from VYNE instead.

View recent insider trading info

Funds Holding VYNE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VYNE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STUART IAIN CHIEF SCIENTIFIC OFFICER

  • Officer
155,129 2021-09-30 6

DOMZALSKI DAVID PRESIDENT AND CEO

  • Officer
  • Director
762,815 2021-09-30 8

HARSCH MUTYA CHIEF LEGAL OFFICER AND GC

  • Officer
164,697 2021-09-30 7

ZERONDA TYLER INTERIM CFO

  • Officer
83,348 2021-09-30 4

LEPORE PATRICK G

  • Director
50,000 2021-08-25 5

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
4,935,057 2021-08-16 4

BARBARI SHARON

  • Director
20,500 2021-07-19 1

BRIGHT REX

  • Director
20,500 2021-07-19 1

BRUNO ANTHONY D

  • Director
20,500 2021-07-19 1

BASTA STEVEN L

  • Director
20,500 2021-07-19 1

SANDOVAL ELISABETH

  • Director
20,500 2021-07-19 1

WILEY MATTHEW T. CHIEF COMMERCIAL OFFICER

  • Officer
109,246 2021-06-30 5

SAIK ANDREW CHIEF FINANCIAL OFFICER

  • Officer
116,468 2021-05-28 3

HIRSCH STANLEY

  • Director
530,019 2020-04-03 0

HADAR ILAN CFO AND COUNTRY MANAGER

  • Officer
0 2020-03-09 0

BALL KRISTINE M SEE REMARKS

  • Officer
52,534 2019-12-11 0

KRASNOW RONALD A. SEE REMARKS

  • Officer
15,819 2019-12-11 0

KWON PAUL CHIEF SCIENTIFIC OFFICER

  • Officer
52,534 2019-12-11 0

BERNS PAUL L

  • Director
0 2019-06-25 0

MCGIRR DAVID W J

  • Director
0 2019-06-25 0

WHITCUP SCOTT M

  • Director
0 2019-06-25 0

ROYSTON AARON

  • Director
0 2019-06-25 0

EBEL TED

  • Director
0 2019-06-25 0

SPELLMAN MARY CHIEF MEDICAL OFFICER

  • Officer
0 2018-12-10 0

PRESIDIO PARTNERS 2007 GP, L.P.

PRESIDIO PARTNERS 2007 (PARALLEL), L.P.

PRESIDIO PARTNERS 2007, L.P.

COLLIER DAVID J

WATSON JAMES F

SOHAIL FAYSAL A.

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-07-24 0

FMR LLC

  • SEE REMARK 1
No longer subject to file 2018-01-29 0

CHA ALBERT

  • Director
7,272,328 2018-01-25 0

VIVO CAPITAL VIII, LLC

VIVO CAPITAL SURPLUS FUND VIII, L.P.

VIVO CAPITAL FUND VIII, L.P.

  • 10% Owner
7,272,328 2018-01-25 0

REMEDITEX VENTURES LLC

  • 10% Owner
2,761,663 2018-01-25 0

VENBIO GLOBAL STRATEGIC FUND II L.P.

  • 10% Owner
No longer subject to file 2018-01-25 0

MERCK & CO., INC.

MERCK SHARP & DOHME CORP.

  • 10% Owner
1,243,168 2018-01-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DOMZALSKI DAVID - Director - Officer PRESIDENT AND CEO

2021-10-01 17:10:46 -0400 2021-09-30 F 13,096 $1.39 d 762,815 direct -5.5556 0.0 0.7937 4 -5.5556 2

ZERONDA TYLER - Officer INTERIM CFO

2021-10-01 17:12:53 -0400 2021-09-30 F 206 $1.39 d 83,348 direct -5.5556 0.0 0.7937 4 -5.5556 2

HARSCH MUTYA - Officer CHIEF LEGAL OFFICER AND GC

2021-10-01 17:11:05 -0400 2021-09-30 F 1,484 $1.39 d 164,697 direct -5.5556 0.0 0.7937 4 -5.5556 2

STUART IAIN - Officer CHIEF SCIENTIFIC OFFICER

2021-10-01 17:12:27 -0400 2021-09-30 F 1,480 $1.39 d 155,129 direct -5.5556 0.0 0.7937 4 -5.5556 2

STUART IAIN - Officer CHIEF SCIENTIFIC OFFICER

2021-09-03 17:34:41 -0400 2021-09-02 A 60,859 a 156,609 direct -3.0488 -9.7561 -32.3171 0.0 1 -32.3171 31

HARSCH MUTYA - Officer CHIEF LEGAL OFFICER AND GC

2021-09-03 17:34:19 -0400 2021-09-02 A 60,860 a 60,860 direct

ZERONDA TYLER - Officer INTERIM CFO

2021-09-03 17:35:04 -0400 2021-09-02 A 60,859 a 83,554 direct -3.0488 -9.7561 -32.3171 0.0 1 -32.3171 31

DOMZALSKI DAVID - Director - Officer PRESIDENT AND CEO

2021-09-03 17:33:17 -0400 2021-09-02 A 320,313 a 320,313 direct

HARSCH MUTYA - Officer CHIEF LEGAL OFFICER AND GC

2021-09-03 17:34:19 -0400 2021-09-02 A 60,859 a 166,181 direct -3.0488 -9.7561 -32.3171 0.0 1 -32.3171 31

STUART IAIN - Officer CHIEF SCIENTIFIC OFFICER

2021-09-03 17:34:41 -0400 2021-09-02 A 60,860 a 60,860 direct

DOMZALSKI DAVID - Director - Officer PRESIDENT AND CEO

2021-09-03 17:33:17 -0400 2021-09-02 A 320,312 a 775,911 direct -3.0488 -9.7561 -32.3171 0.0 1 -32.3171 31

ZERONDA TYLER - Officer INTERIM CFO

2021-09-03 17:35:04 -0400 2021-09-02 A 60,860 a 60,860 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VYNE THERAPEUTICS INC VYNE 2021-10-26 19:15:03 UTC -2.4821 2.5521 1000000
VYNE THERAPEUTICS INC VYNE 2021-10-26 18:45:03 UTC -2.5064 2.5764 1000000
VYNE THERAPEUTICS INC VYNE 2021-10-26 18:15:03 UTC -2.5064 2.5764 1000000
VYNE THERAPEUTICS INC VYNE 2021-10-26 17:45:03 UTC -2.5064 2.5764 1000000
VYNE THERAPEUTICS INC VYNE 2021-10-26 17:15:03 UTC -2.5064 2.5764 1000000
VYNE THERAPEUTICS INC VYNE 2021-10-26 16:45:04 UTC -2.408 2.478 1100000
VYNE THERAPEUTICS INC VYNE 2021-10-26 16:15:03 UTC -2.408 2.478 1100000
VYNE THERAPEUTICS INC VYNE 2021-10-26 15:45:03 UTC -2.408 2.478 1100000
VYNE THERAPEUTICS INC VYNE 2021-10-26 15:15:03 UTC -2.408 2.478 1100000
VYNE THERAPEUTICS INC VYNE 2021-10-26 14:45:03 UTC -3.3102 3.3802 1200000
VYNE THERAPEUTICS INC VYNE 2021-10-26 14:15:05 UTC -3.3102 3.3802 1200000
VYNE THERAPEUTICS INC VYNE 2021-10-26 13:45:03 UTC -3.3102 3.3802 1200000
VYNE THERAPEUTICS INC VYNE 2021-10-26 13:15:03 UTC -3.3102 3.3802 1200000
VYNE THERAPEUTICS INC VYNE 2021-10-26 12:45:03 UTC -3.3102 3.3802 1200000
VYNE THERAPEUTICS INC VYNE 2021-10-25 22:15:03 UTC -3.3102 3.3802 1200000
VYNE THERAPEUTICS INC VYNE 2021-10-25 21:45:03 UTC -3.3102 3.3802 1200000
VYNE THERAPEUTICS INC VYNE 2021-10-25 21:15:03 UTC -3.3102 3.3802 1200000
VYNE THERAPEUTICS INC VYNE 2021-10-25 20:45:03 UTC -3.3102 3.3802 1200000
VYNE THERAPEUTICS INC VYNE 2021-10-25 20:15:03 UTC -3.3102 3.3802 1200000
VYNE THERAPEUTICS INC VYNE 2021-10-25 19:45:04 UTC -3.3102 3.3802 1200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments